predictive technology
Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery
Premium
Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions.
Rare Disease Screening Firm 3billion Closes $13M Series C Financing
The Korean molecular diagnostics firm, a spinoff from genomic services provider Macrogen
Novigenix-Led Consortium Awarded Up to €1M to Develop Predictive Immune Checkpoint Inhibitor Test
Earlier this year, Novigenix and collaborators were awarded up to €1 million to develop a blood-based multi-omics colorectal cancer assay.
Norwegian Diagnostics Firm Age Labs to Develop Epigenetics-Based Test for SARS-CoV-2
The Oslo-based company plans to develop a test that can identify high-risk individuals based on an epigenetic signature.
Takeda, MiTest Health Partner to Expand Use of Crohn's Disease Risk Prediction Tool
Takeda said that the tool evaluates risk for developing complications associated with Crohn's disease and helps support personalized clinical decision-making.